[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Skryabina et al., 2023 - Google Patents

Structure and mechanism of action of botulinum and tetanus neurotoxins: A review

Skryabina et al., 2023

View PDF
Document ID
6099355473147692948
Author
Skryabina A
Golenok E
Sobkh M
Nikiforov V
Publication year
Publication venue
Epidemiology and Infectious Diseases

External Links

Snippet

АННОТАЦИЯ Ботулинические нейротоксины и столбнячный нейротоксин являются самыми сильными из известных токсинов и вызывают развитие нейропаралитических синдромов при ботулизме и столбняке. Данная статья систематизирует научные …
Continue reading at rjeid.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/5308—Immunoassay; Biospecific binding assay for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Similar Documents

Publication Publication Date Title
Dong et al. Botulinum and tetanus neurotoxins
Rossetto et al. Botulinum neurotoxins: mechanism of action
Rossetto et al. Botulinum neurotoxins: genetic, structural and mechanistic insights
Megighian et al. Tetanus and tetanus neurotoxin: From peripheral uptake to central nervous tissue targets
Restani et al. Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons
Schiavo et al. Neurotoxins affecting neuroexocytosis
Binz et al. Cell entry strategy of clostridial neurotoxins
Marinelli et al. The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes
Caleo et al. Transynaptic action of botulinum neurotoxin type A at central cholinergic boutons
Herreros et al. Tetanus toxin fragment C binds to a protein present in neuronal cell lines and motoneurons
CN102325792B (en) For producing the means and method of high-purity neurotoxin
Pellett et al. Botulinum neurotoxins A, B, C, E, and F preferentially enter cultured human motor neurons compared to other cultured human neuronal populations
Azarnia Tehran et al. A novel inhibitor prevents the peripheral neuroparalysis of botulinum neurotoxins
Brunger et al. Highly specific interactions between botulinum neurotoxins and synaptic vesicle proteins
Hussain et al. The discovery of the soluble N-ethylmaleimide-sensitive factor attachment protein receptor complex and the molecular regulation of synaptic vesicle transmitter release: the 2010 Kavli Prize in neuroscience
Wild et al. In vitro potency determination of botulinum neurotoxin B based on its receptor-binding and proteolytic characteristics
Fantini Lipid rafts and human diseases: why we need to target gangliosides
Skryabina et al. Structure and mechanism of action of botulinum and tetanus neurotoxins: A review
Stern et al. Replacing the mouse bioassay for diagnostics and potency testing of botulinum neurotoxins–progress and challenges
Zhang et al. Mastoparan-7 rescues botulinum toxin-A poisoned neurons in a mouse spinal cord cell culture model
Kutschenko et al. BoNT/AB hybrid maintains similar duration of paresis as BoNT/A wild-type in murine running wheel assay
Schiavo et al. The structure and mode of action of botulinum and tetanus toxins
Ambrin et al. Critical analysis in the advancement of cell-based assays for botulinum neurotoxin
Kitzman VGLUT1 and GLYT2 labeling of sacrocaudal motoneurons in the spinal cord injured spastic rat
Takemoto et al. Immunohistochemical evidence for the localization of neurons containing the putative transmitter L-proline in rat brain